Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
by
Inui, Naoki
, Nakamura, Yutaro
, Suda, Takafumi
, Furuhashi, Kazuki
, Kono, Masato
, Inoue, Yusuke
, Enomoto, Noriyuki
, Yokomura, Koshi
, Suzuki, Yuzo
, Hasegawa, Hirotsugu
, Karayama, Masato
, Fujisawa, Tomoyuki
, Kato, Shinpei
, Nakamura, Hidenori
, Hozumi, Hironao
in
Acute exacerbation
/ Aged
/ Aged, 80 and over
/ Arthritis, Rheumatoid - complications
/ Case-Control Studies
/ Complications and side effects
/ Decision Trees
/ Female
/ Humans
/ Interstitial lung disease
/ Lung diseases, Interstitial
/ Lung Diseases, Interstitial - etiology
/ Lung Diseases, Interstitial - mortality
/ Male
/ Medicine
/ Medicine & Public Health
/ Mortality
/ Mortality prediction model
/ Patient outcomes
/ Pneumology/Respiratory System
/ Prognosis
/ Prognostic factor
/ Retrospective Studies
/ Rheumatoid arthritis
/ Risk factors
/ Vital Capacity
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
by
Inui, Naoki
, Nakamura, Yutaro
, Suda, Takafumi
, Furuhashi, Kazuki
, Kono, Masato
, Inoue, Yusuke
, Enomoto, Noriyuki
, Yokomura, Koshi
, Suzuki, Yuzo
, Hasegawa, Hirotsugu
, Karayama, Masato
, Fujisawa, Tomoyuki
, Kato, Shinpei
, Nakamura, Hidenori
, Hozumi, Hironao
in
Acute exacerbation
/ Aged
/ Aged, 80 and over
/ Arthritis, Rheumatoid - complications
/ Case-Control Studies
/ Complications and side effects
/ Decision Trees
/ Female
/ Humans
/ Interstitial lung disease
/ Lung diseases, Interstitial
/ Lung Diseases, Interstitial - etiology
/ Lung Diseases, Interstitial - mortality
/ Male
/ Medicine
/ Medicine & Public Health
/ Mortality
/ Mortality prediction model
/ Patient outcomes
/ Pneumology/Respiratory System
/ Prognosis
/ Prognostic factor
/ Retrospective Studies
/ Rheumatoid arthritis
/ Risk factors
/ Vital Capacity
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
by
Inui, Naoki
, Nakamura, Yutaro
, Suda, Takafumi
, Furuhashi, Kazuki
, Kono, Masato
, Inoue, Yusuke
, Enomoto, Noriyuki
, Yokomura, Koshi
, Suzuki, Yuzo
, Hasegawa, Hirotsugu
, Karayama, Masato
, Fujisawa, Tomoyuki
, Kato, Shinpei
, Nakamura, Hidenori
, Hozumi, Hironao
in
Acute exacerbation
/ Aged
/ Aged, 80 and over
/ Arthritis, Rheumatoid - complications
/ Case-Control Studies
/ Complications and side effects
/ Decision Trees
/ Female
/ Humans
/ Interstitial lung disease
/ Lung diseases, Interstitial
/ Lung Diseases, Interstitial - etiology
/ Lung Diseases, Interstitial - mortality
/ Male
/ Medicine
/ Medicine & Public Health
/ Mortality
/ Mortality prediction model
/ Patient outcomes
/ Pneumology/Respiratory System
/ Prognosis
/ Prognostic factor
/ Retrospective Studies
/ Rheumatoid arthritis
/ Risk factors
/ Vital Capacity
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
Journal Article
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Background
Patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), like those with idiopathic pulmonary fibrosis (IPF), might develop an unexpected acute exacerbation (AE)—a rapidly progressing and deadly respiratory decline. Although AE incidence and risk factors in RA-ILD patients are known, their post-AE clinical course remains unknown owing to the rarity of AE-RA-ILD. This multicentre retrospective study evaluated post-AE mortality and prognostic variables in AE-RA-ILD patients and created a mortality prediction model for AE-RA-ILD.
Methods
This research comprised 58 patients with AE-RA-ILD and 96 with AE-IPF (a control disease). Multivariate Cox regression analysis was performed to identify prognostic variables. A prediction model was created with recursive partitioning (decision tree).
Results
The post-AE 90-day mortality rate in the overall AE-RA-ILD group was 48.3%; percent predicted forced vital capacity within 12 months before AE onset (baseline %FVC) and PaO
2
/FiO
2
ratio at AE onset (P/F at AE) were independent predictors of mortality. Post-AE 90-day mortality rates were 40.6% and 43.8%, respectively, in AE-RA-ILD and AE-IPF patients propensity score-matched for age, sex, baseline %FVC and P/F at AE (
P
= 1.0000). In AE-RA-ILD patients,
C
-indices of baseline %FVC and P/F at AE to predict post-AE 90-day mortality were 0.604 and 0.623, respectively. A decision tree model based on these prognostic factors classified AE-RA-ILD patients into mild, moderate and severe groups (post-AE 90-day mortality rates: 20.8%, 64.0% and 88.9%, respectively;
P
= 0.0002); the
C
-index improved to 0.775.
Conclusions
Post-AE mortality was high in AE-RA-ILD patients similar to AE-IPF patients. The discovered prognostic factors and our mortality prediction model may aid in the management of AE-RA-ILD patients.
Publisher
BioMed Central,BioMed Central Ltd,BMC
This website uses cookies to ensure you get the best experience on our website.